Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | RARB | P10826 | 2/20 | 0.37 |
| ▸ | BDKRB2 | P30411 | 2/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propanol SCHEMBL27878368 | 0.97 | TP53 (0.39) | TP53HRH3SMN1; SMN2L3MBTL1HPGD | |
| Alcohol SCHEMBL2443956 | 0.85 | — | — | |
| Biphenyl SCHEMBL20583591 | 0.84 | ALDH1A1 (0.53) | TP53SMN1; SMN2L3MBTL1HPGDALDH1A1 | |
| 1-Pentanol SCHEMBL27970578 | 0.82 | SMN1; SMN2 (0.67) | TP53HRH3SMN1; SMN2ALDH1A1MAPT | |
| Butane SCHEMBL28006675 | 0.77 | HRH3 (0.43) | TP53HRH3SMN1; SMN2L3MBTL1HPGD | |
| Butane SCHEMBL27529761 | 0.77 | HRH3 (0.43) | TP53HRH3SMN1; SMN2L3MBTL1HPGD | |
| Propane SCHEMBL28440529 | 0.76 | — | — | |
| P-Xylene SCHEMBL4079357 | 0.76 | ACHE (0.53) | SMN1; SMN2ALDH1A1MAPTLMNACYP1A2 | |
| Propanol SCHEMBL8328980 | 0.76 | ALDH1A1 (0.58) | SMN1; SMN2ALDH1A1MAPTLMNAMEN1 | |
| Propanol SCHEMBL29500448 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240175141-A1 | BIOBASED AND BIODEGRADABLE CORROSION INHIBITION COMPOSITION | ZestBio, Inc. | 2024-05-30 | — | — | US | disclosed |
| US-20200331828-A1 | NOVEL COMPOUNDS WHICH ACTIVATE ESTROGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USING THE SAME | UNIV ILLINOIS (US) | 2020-10-22 | — | — | US | disclosed |
| US-10703698-B2 | Compounds which activate estrogen receptors and compositions and methods of using the same | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2020-07-07 | — | — | US | disclosed |
| US-20190002380-A1 | NOVEL COMPOUNDS WHICH ACTIVATE ESTROGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USING THE SAME | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2019-01-03 | — | — | US | disclosed |
| CN-108409837-A | One group of glycopeptide compound, preparation method and application with anti-drug resistance bacterial activity | 上海来益生物药物研究开发中心有限责任公司 | 2018-08-17 | — | — | CN | disclosed |
| CN-106132932-A | Azepane Derivatives And Methods Of Treating Hepatitis B Infections | 诺维拉治疗公司 | 2016-11-16 | — | — | CN | disclosed |
| EP-1808497-B1 | ISOCYCLOMALTOOLIGOSACCHARIDE, ISOCYCLOMALTOOLIGOSACCHARIDE SYNTHASE, PROCESS FOR PRODUCING THEM AND USE THEREOF | HAYASHIBARA CO (JP) | 2014-10-08 | — | — | EP | disclosed |
| US-8633005-B2 | Isocyclomaltooligosaccharide(s), isocyclomaltooligosaccharide-forming enzyme, their preparation and uses | Hayashibara Co., Ltd. (JP) | 2014-01-21 | — | — | US | disclosed |
| CN-101781162-B | Method for preparing trifluoromethyl styrene compound | SHANGHAI CHEMEXPLORER CO LTD | 2013-12-11 | — | — | CN | disclosed |
| CN-101781161-B | Method for preparing trifluoromethyl styrene compound | SHANGHAI CHEMEXPLORER CO LTD | 2013-11-27 | — | — | CN | disclosed |
| US-7901701-B2 | Methods for producing dried pesticide compositions | LIGNOTECH USA, INC. (US) | 2011-03-08 | — | — | US | disclosed |
| US-20100285562-A1 | ISOCYCLOMALTOOLIGOSACCHARIDE(S), ISOCYCLOMALTOOLIGOSACCHARIDE-FORMING ENZYME, THEIR PREPARATION AND USES | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2010-11-11 | — | — | US | disclosed |
| US-20100278890-A1 | Use of Lignosulfonates in Suspo-emulsions for Producing Pesticide Compositions | LIGNOTECH USA, INC. (US) | 2010-11-04 | — | — | US | disclosed |
| US-20100233050-A1 | Hardwood Lignosulfonates for Separating Gangue Materials From Metallic Sulfide Ores | LIGNOTECH USA, INC. (US) | 2010-09-16 | — | — | US | disclosed |
| US-7732426-B2 | Isocyclomaltooligosaccharide (S) , isocyclomaltooligosaccharide-forming enzyme, their preparation and uses | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2010-06-08 | — | — | US | disclosed |
| US-20090110707-A1 | Methods for Producing Pesticide Compositions | LIGNOTECH USA, INC. | 2009-04-30 | — | — | US | disclosed |
| US-20080131468-A1 | Isocyclomaltooligosaccharide (S) , Isocyclomaltooligosaccharide-Forming Enzyme, Their Preparation and Uses | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2008-06-05 | — | — | US | disclosed |
| EP-1808497-A1 | ISOCYCLOMALTOOLIGOSACCHARIDE, ISOCYCLOMALTOOLIGOSACCHARIDE SYNTHASE, PROCESS FOR PRODUCING THEM AND USE THEREOF | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) | 2007-07-18 | — | — | EP | disclosed |
| US-6008240-A | AN ANTAGONIST OF HISTAMINE H3 RECEPTORS; FOR TREATING ALLERGY, INFLAMMATION, CARDIOVASCULAR DISEASE (HYPER OR HYPOTENSION), GASTROINTESTINAL DISORDERS, CNS DISORDERS INVOLVING ATTENTION OR COGNITIVE DISORDERS | GLIATECH, INC. (US) | 1999-12-28 | — | — | US | disclosed |
| US-3932534-A | NI, AL, MG, ZN OXIDE CATALYST | KYOWA KAGAKU KOGYO KABUSHIKI KAISHI (JA) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10703698-B2 | Compounds which activate estrogen receptors and compositions and methods of using the same | GPER1, ESRRG, ESR2 | TP53 195/4885HRH3 1930/4885SMN1; SMN2 3813/4885 |
| US-20190002380-A1 | NOVEL COMPOUNDS WHICH ACTIVATE ESTROGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USING THE SAME | GPER1, ESRRG, ESR2 | TP53 214/4885HRH3 2184/4885SMN1; SMN2 3660/4885 |
| US-20200331828-A1 | NOVEL COMPOUNDS WHICH ACTIVATE ESTROGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USING THE SAME | GPER1, ESRRG, ESR2 | TP53 214/4885HRH3 2184/4885SMN1; SMN2 3660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.